GlassScriptPhysician profile
Kunal Bakshi
NPI 1033591037
$3,066.06
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.32 · 2022: $484 · 2023: $1,557 · 2024: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,558.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,155.88 | 2022-2024 | Biktarvy |
| Viiv Healthcare Company | $702.81 | 2021-2024 | Dovato, Cabenuva, Apretude |
| Janssen Biotech, INC. | $346.46 | 2022-2023 | Symtuza |
| Merck Sharp & Dohme LLC | $258.50 | 2022-2024 | Pifeltro, Delstrigo |
| Emd Serono, INC. | $81.19 | 2022-2024 | Serostim |
| Abbvie INC. | $60.85 | 2022-2024 | Mavyret |
| Glaxosmithkline, LLC. | $55.57 | 2023-2024 | Pediarix, Bexsero, Shingrix |
| Theratechnologies INC. | $47.96 | 2023 | Trogarzo, Egrifta |
| Indivior INC. | $47.34 | 2022-2023 | Perseris |
| Napo Pharmaceuticals INC | $39.25 | 2023-2024 | Mytesi |
| Hologic Sales and Service, LLC | $34.47 | 2022-2023 | Aptima |
| Vbi Vaccine (Delaware) INC. | $34.36 | 2022 | |
| Alkermes, INC. | $29.07 | 2023-2024 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $28.94 | 2024 | Invega Trinza, Invega Sustenna |
| Lilly USA, LLC | $27.52 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.66 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $23.50 | 2023 | Austedo Xr |
| Exact Sciences Corporation | $23.20 | 2024 | Cologuard Collection Kit |
| Organon LLC | $21.66 | 2023 | Nexplanon |
| Edwards Lifesciences Corporation | $20.87 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Bakshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.